Should Integrilin be an Integral Part of Adjunctive Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction?
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Eptifibatide (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 30 Jun 2021 Planned End Date changed from 1 Oct 2014 to 1 Jun 2021.
- 30 Jun 2021 Status changed from active, no longer recruiting to withdrawn prior to enrolment, due to lack of funding.
- 08 Aug 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.